Statement on arrangements for pricing branded medicines from 2014
The Association of the British Pharmaceutical Industry and the Department of Health have published a Joint DH/ABPI statement
Applies to England
Documents
Details
The negotiations, which are set to begin in September, will determine the arrangements for pricing branded medicines in the UK from 2014, including medicines that are already on the market in December 2013 and new medicines which are launched from January 1 2014.